Shobanbabu Bommagani Institution Verified

Sourced from institutional research profiles (UAMS TRI or ARA).

Researcher

University of Arkansas for Medical Sciences

faculty

7 h-index 36 pubs 262 cited

Edit your profile

Biography and Research Information

OverviewAI-generated summary

Shobanbabu Bommagani's research focuses on molecular mechanisms relevant to health and disease, with an emphasis on protein structure and function. His work includes investigating the structural basis of interactions between viral proteins and human enzymes, as seen in his studies of SARS-CoV-2 Nsp3 macrodomain complexes and their relationship with human poly(ADP-ribose) glycohydrolase (PARG). Bommagani also examines the potential therapeutic implications of molecular interventions, including the evaluation of drug delivery systems and their effects on cellular health. His publications explore topics such as the bone and kidney toxicity of potential antibiotic delivery agents and the mitigation of drug-induced glomerular cell damage. Bommagani has published 36 papers, accumulating 262 citations, and holds an h-index of 7. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Darin E. Jones, Abdul H. Khan, Abhishek Mishra, and John D. Imig.

Metrics

  • h-index: 7
  • Publications: 36
  • Citations: 262

Selected Publications

  • EET-Based Therapeutics Mitigate Sorafenib-Associated Glomerular Cell Damage (2025) DOI
  • Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors (2021) DOI
  • Evaluation of bone and kidney toxicity of BT2-peg2, a potential carrier for the targeted delivery of antibiotics to bone (2021) DOI

Grants & Funding

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics